Biotech is gathering pace: AI systems are simulating novel materials, new genomic technologies are enabling precision bioengineering, and automation is executing production on a massive scale. Softbank Vision Fund Senior Managing Partner, Deep Nishar tells Azeem Azhar why biotech is the next trillion-dollar market, and what breakthroughs to expect.
In this episode they also discuss:
- Why emerging biotech and AI, together, would help control and stop coronavirus-like outbreaks in the future.
- What new materials and medicines are coming out of the “virtuous cycle” of research and funding that is now taking off.
- What the rest of the world should learn from China’s vigorous development of AI technologies.
Further reading:
- “As Zymergen Buys EnEvolv, Biological Manufacturing Is Ready To Transform How Industry Makes Everything From Airplanes To Air Jordans” (Forbes, 2020)
- “AI just found a new type of antibiotics” (Vox, 2020)
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
